Connection

Andreas Nitsche to Germany

This is a "connection" page, showing publications Andreas Nitsche has written about Germany.
Connection Strength

0.094
  1. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis. 2021 08; 27(8):2174-2178.
    View in: PubMed
    Score: 0.019
  2. [Recording of SARS-CoV-2 laboratory tests in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Apr; 64(4):403-411.
    View in: PubMed
    Score: 0.018
  3. [Monitoring of COVID-19 by extending existing surveillance for acute respiratory infections]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Apr; 64(4):395-402.
    View in: PubMed
    Score: 0.018
  4. Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020. Euro Surveill. 2020 11; 25(47).
    View in: PubMed
    Score: 0.018
  5. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill. 2013 Feb 21; 18(8).
    View in: PubMed
    Score: 0.011
  6. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012 Dec 06; 17(49).
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.